The Ambrox route is the clearest case. The molecule is settled: (−)-Ambrox made from fermentation-derived (E)-β-farnesene through (E,E)-homofarnesol and an engineered squalene-hopene cyclase, described by the company as an industrial-scale route with better atom and step economy than the sclareol synthesis. What the filings since then protect are the fragile points around it.
Growth in the regions is being bought as well as built
2 / 8
The largest single move is the agreement to take a 70% stake in Eurofragance, the Barcelona fine-fragrance house. The Moroccan competition authority's notice of the concentration, published in July 2026, describes Givaudan acquiring exclusive control through 70% of the share capital and voting rights. Givaudan's own announcement puts Eurofragance's business at roughly CHF 185 million of incremental 2025 sales on a proforma basis, with closing subject to regulatory approval. The Casablanca development hub follows the same logic: opened in September 2026 with application and perfumery laboratories and a commercial team for the Maghreb and West Africa.
Strategy
The defensible asset has moved off the molecule
3 / 8
Across the areas, the filings claim formulations, carriers and methods rather than new ingredients. A precursor's worth is its release chemistry; an active's worth is the carrier that gets it into the skin, in this case hyaluronic acid absorbed into activated smectite clay; a colourant's worth is the complex that holds it stable; a sweetener's worth is the modifier library around it, claimed as a narrow dose window rather than a molecule.
Research
The cyclase is a platform, and it is being pointed at other molecules
4 / 8
Amberketal is the second target. An enzyme-mediated route cyclises an acyclic acetate and then hydrolyses it. The substrate side is being rebuilt too: selective epoxidation of β-farnesene's 1,3-diene with a metal-salen or porphyrin catalyst, a route through an epoxide mixture to acetylmethylfarnesol and hydroxy-farnesylacetone, and a protected hydroxyfarnesylacetonate that releases the cyclisation substrate in situ. The same enzyme class is claimed for 2-oxygenated decalins at high regioisomeric and diastereomeric purity. Where the enzyme does not reach, the estate works on the molecule anyway: sedgeone by allylic oxidation over an iron phthalocyanine catalyst, chosen because the substrate has several oxidation-sensitive sites.
Market
The launches that reach the market are the delivery ones
5 / 8
The products with a public launch date sit in the delivery lines. Scentaurus Aquamelon, an oxygen-activated precursor for hair care, arrived in June 2026; Scentaurus PolyDoux, a raspberry-vanilla precursor for hair and fabric care, in February 2026 [[https://www.premiumbeautynews.com/en/givaudan-unveils-fruity-gourmand,27135]]. PlanetCaps was extended to personal care in November 2025, and in July 2026 the company took an equity stake in Microcaps, an ETH Zurich spin-off, to work on precision encapsulation for alcohol-free fine fragrance. The pattern is consistent: the market sees the delivery chemistry, and the molecule work behind it stays in the filings.
Strategy
Compliance is being built as a capability, not treated as overhead
6 / 8
The legal and compliance side of the business has started appearing as numbers in the accounts rather than as a background condition. The first half of 2026 carried CHF 103 million of non-recurring costs attributed mainly to litigation settlements and provisions, and net income came in at CHF 475 million against a consensus of CHF 554 million, a charge one analyst called "not well anticipated". The operational answer — customs capability, safety management, competition-law hygiene — stays internal, and the tariff thread runs the same way: where duties were recovered, they are repaid to customers, so the company carries the timing and the administrative cost and the customer keeps the relationship.
Research
The growing part of the fragrance portfolio is release chemistry
7 / 8
Precursors are odourless molecules that release a fragrance on a trigger, and the estate now covers several triggers and several released classes. Unsaturated ethers release aldehydic notes. N-alkyl anthranilates and o-aminoalkylphenones release alkyl anthranilates and aldehydes by spontaneous oxidative cleavage on ambient oxygen, and are claimed as colour-stable where Schiff bases are not. A carbonyl enol ether releases carbonyl enols, alcohols, aldehydes or ketones. Ethers and esters of fragrant alcohols release over days on air and humidity. Homoallyl ethers release vanillin and eugenol without the discolouration the free phenolics cause. Thioether precursors release fruity ketones and carry a suppressant at 0.1–3.0 wt% against the thiol off-odour the chemistry itself generates. The mechanism behind that family has been published: a δ-cleavage of β-alkylthioalkanones in ambient air, proposed as a Pummerer-type rearrangement, releasing β-mercaptoketones that occur naturally in fruit.
Market
The receptor work is the one piece of science the company markets directly
8 / 8
In November 2025 Givaudan announced what it called a breakthrough in scent receptor research, describing receptors it had unlocked and the sensitivity gains that followed. Trade coverage framed it as mapping twenty human scent receptors and linking that map to perfume creation. The commercial face of the same work is ChériScentz, launched in May 2025 as a design tool for perfumers. The announcement describes what the work enables; the assay and the screening method underneath it are not part of the public story.